|
|
Development of correction formula for field potential duration of human induced pluripotent stem cell-derived cardiomyocytes sheets
|
|
|
|
|
نویسنده
|
izumi-nakaseko h. ,kanda y. ,nakamura y. ,hagiwara-nagasawa m. ,wada t. ,ando k. ,naito a.t. ,sekino y. ,sugiyama a.
|
منبع
|
journal of pharmacological sciences - 2017 - دوره : 135 - شماره : 1 - صفحه:44 -50
|
چکیده
|
Human induced pluripotent stem cell-derived cardiomyocytes (hipsc-cms) have been used in many studies to assess proarrhythmic risks of chemical compounds. in those studies,field potential durations (fpd) of hipsc-cms have been corrected by clinically used fridericia's and/or bazett's formulae,however,the rationale for the use of these formulae has not been well established. in the present study,we developed a correction formula for experiments using hipsc-cms. first,we analyzed the effect of beating rate on fpd in the hipsc-cms sheets with electrical stimuli and a hcn channel inhibitor zatebradine. next,we examined the relationship between the electrophysiological properties and the expression levels of ion channel genes in the cell sheets. zatebradine slowed the beating rate and allowed to analyze fpd changes at various pacing cycle lengths. rate-dependent change in the repolarization period was smaller in the cell sheets than that reported on the human hearts,which can be partly explained by lower gene expression level of hkcnj2 and hkcne1. thus,non-linear equation for correcting fpd in the cell sheet; fpdc = fpd/rr0.22 with rr given in second was obtained,which may make it feasible to assess net repolarization delay by various chemical compounds with a chronotropic action. © 2017 the authors
|
کلیدواژه
|
Correction formula; Field potential duration; Human induced pluripotent stem cell-derived cardiomyocytes
|
آدرس
|
department of pharmacology,faculty of medicine,toho university,5-21-16 omori-nishi,ota-ku,tokyo,143-8540, Japan, division of pharmacology,national institute of health sciences,1-18-1 kamiyoga,setagaya-ku,tokyo,158-8501, Japan, department of pharmacology,faculty of medicine,toho university,5-21-16 omori-nishi,ota-ku,tokyo,143-8540, Japan, department of pharmacology,faculty of medicine,toho university,5-21-16 omori-nishi,ota-ku,tokyo,143-8540, Japan, department of pharmacology,faculty of medicine,toho university,5-21-16 omori-nishi,ota-ku,tokyo,143-8540,japan,department of cardiology,juntendo university school of medicine,urayasu hospital heart center,2-1-1 tomioka,urayasu,chiba 279-0021, Japan, department of pharmacology,faculty of medicine,toho university,5-21-16 omori-nishi,ota-ku,tokyo,143-8540, Japan, department of pharmacology,faculty of medicine,toho university,5-21-16 omori-nishi,ota-ku,tokyo,143-8540, Japan, department of pharmacology,faculty of medicine,toho university,5-21-16 omori-nishi,ota-ku,tokyo,143-8540,japan,division of pharmacology,national institute of health sciences,1-18-1 kamiyoga,setagaya-ku,tokyo,158-8501,japan,laboratory of chemical pharmacology,graduate school of pharmaceutical sciences,the university of tokyo,7-3-1 hongo bunkyo-ku,tokyo,113-0033, Japan, department of pharmacology,faculty of medicine,toho university,5-21-16 omori-nishi,ota-ku,tokyo,143-8540, Japan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|